<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for PPHM</title>
    <link />
    <description>Headlines for Peregrine Pharmaceuticals</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Encouraging News for Peregrine Pharma  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100139/encouraging-news-for-peregrine-pharma.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 24 May 2013 16:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Encouraging News for Peregrine Pharma  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100094/encouraging-news-for-peregrine-pharma.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 24 May 2013 00:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Peregrine Pharmaceuticals, The Little Biotech With The Golden Goose Of Immunotherapy</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1458401-peregrine-pharmaceuticals-the-little-biotech-with-the-golden-goose-of-immunotherapy.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 23 May 2013 17:49:24 GMT</pubDate>
    </item>
    <item>
      <title>FDA Green Light = Surprise Share Surge</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/fda-green-light-surprise-share-surge/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 20:10:00 GMT</pubDate>
    </item>
    <item>
      <title>These Winners Couldn't Send the Dow to Another Record</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/these-winners-couldnt-send-the-dow-to-another-reco/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 20:02:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/biotech-companies-the-fda-doesnt-care-about-your-p/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 16:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Peregrine Pharmaceuticals Shares Skyrocketed</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/why-peregrine-pharmaceuticals-shares-skyrocketed/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 13:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3603360/peregrine-pharmaceuticals-reaches-agreement-with-fda-on-a-phase-iii-trial-design-.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 20 May 2013 08:48:43 GMT</pubDate>
    </item>
    <item>
      <title>Osiris Loss In-Line with Expectations - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98971/osiris-loss-in-line-with-expectations.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 17:35:01 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1402281-biotech-watchlist-2013-update-exciting-ideas-have-explosive-potential.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 22:18:32 GMT</pubDate>
    </item>
    <item>
      <title>Is Peregrine Preparing to Soar Again?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/29/is-peregrine-preparing-to-soar-again/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 29 Apr 2013 20:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Peregrine Closes Patient Enrollment in Breast Cancer Clinical Trial for Bavituximab</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3537473/peregrine-closes-patient-enrollment-in-breast-cancer-clinical-trial-for-bavituxim.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 29 Apr 2013 08:38:49 GMT</pubDate>
    </item>
    <item>
      <title>Threshold: My Biotech Pick Of The Year</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1361021-threshold-my-biotech-pick-of-the-year.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 08:43:25 GMT</pubDate>
    </item>
    <item>
      <title>Peregrine Pharmaceuticals Hosts Annual Meeting; Highlights Bavituximab's Potential in Solid Tumor Th</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3485712/peregrine-pharmaceuticals-hosts-annual-meeting-highlights-bavituximabs-potential-.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 10 Apr 2013 08:37:48 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Under $10 Set to Soar</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-under-10-set-soar.html-23.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 04 Apr 2013 13:53:00 GMT</pubDate>
    </item>
    <item>
      <title>Follow The Crashing Biotechs: 4 Stocks Fresh From A Fall</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1290071-follow-the-crashing-biotechs-4-stocks-fresh-from-a-fall.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Mar 2013 15:03:51 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks That Blew the Market Away</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/18/3-stocks-that-blew-the-market-away-25/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 18 Mar 2013 12:17:00 GMT</pubDate>
    </item>
    <item>
      <title>A Fool Looks Back</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/16/a-fool-looks-back-25/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 16 Mar 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Peregrine Releases Earnings, But The Situation Remains The Same</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1271741-peregrine-releases-earnings-but-the-situation-remains-the-same.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Mar 2013 17:29:37 GMT</pubDate>
    </item>
    <item>
      <title>Peregrine Reports Narrower Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94707/peregrine-reports-narrower-loss.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 13 Mar 2013 17:19:01 GMT</pubDate>
    </item>
  </channel>
</rss>
